Cyrana C Gallay
Overview
Explore the profile of Cyrana C Gallay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quigley B, Wellington N, Levenstein J, Dutton M, Boucas A, Forsyth G, et al.
Sci Rep
. 2025 Feb;
15(1):7176.
PMID: 40021745
The aim of this study was to advance post-traumatic stress disorder (PTSD) understanding in older adults (48-77 years) by determining if circulating cytokines (IL-1β, IL-2, IL-4, IL-6, IL-12p70, IL17A and...
2.
Quigley B, Can A, Dutton M, Gallay C, Forsyth G, Jones M, et al.
Eur Neuropsychopharmacol
. 2025 Jan;
93:17-18.
PMID: 39879838
No abstract available.
3.
Electrophysiological phenotypes of suicidality predict prolonged response to oral ketamine treatment
Can A, Schwenn P, Isbel B, Beaudequin D, Boucas A, Dutton M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2022 Dec;
123:110701.
PMID: 36565983
Oral ketamine has shown to be a rapid-acting antidepressant and a potential treatment option for suicidality, however, repeated doses are often required. Objective markers of prolonged treatment response are needed...
4.
Dutton M, Can A, Beaudequin D, Jensen E, Jones M, Gallay C, et al.
J Affect Disord
. 2022 Jan;
300:410-417.
PMID: 35016117
Background: Stress is prevalent in people experiencing suicidality and is a major contributor to the development of mental disorders. Evidence suggests ketamine shows capacity to reverse stress-induced brain changes. Though...
5.
Gallay C, Forsyth G, Can A, Dutton M, Jamieson D, Jensen E, et al.
Psychiatry Res Neuroimaging
. 2021 Aug;
317:111369.
PMID: 34461430
Chronic suicidality has been associated with neuronal atrophy in cortico-striato-limbic regions and is thought to be mediated via a glutamatergic imbalance. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been posited...
6.
Can A, Hermens D, Dutton M, Gallay C, Jensen E, Jones M, et al.
Transl Psychiatry
. 2021 Feb;
11(1):101.
PMID: 33542187
Recently, low-dose ketamine has been proposed as a rapid-acting treatment option for suicidality. The majority of studies to date have utilised intravenous (IV) ketamine, however, this route of administration has...